Books and documentaries

Kjaergard LL, Liu JP, Gluud C. How to assess the quality of evidence on intervention effects. In: Wang J, Gluud C, eds. Evidence-based medicine and clinical practice. Beijing: Science Publisher. 2002: 55-61.

Gluud C, Wang J. History of evidence-based medicine. In: Wang J, Gluud C, eds. Evidence-based medicine and clinical practice. Beijing: Science Publisher. 2002: 2-4.

Gluud C. The Cochrane Collaboration. In: Wang J, Gluud C, eds. Evidence-based medicine and clinical practice. Beijing: Science Publisher. 2002: 327-31.

Gluud C. Endocrine system. In: Sherman D, Preedy V, Watson R, eds. Ethanol and the liver. Mechanisms and management. Bershire: Hardwood Academic Publishers. 2002: 472-94.

Sørensen TIA, D’Amico G, van Buuren HR, Gluud C, Kamath PS, Riggio O, Salerno F, Yacavone RF. Baveno III Consensus Statements: Methodological requirements for future trials. In: de Franchis R, ed. Portal Hypertension III: Proceedings of the third Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science Ltd. 2001: 238-9.

Sørensen TIA, D’Amico G, van Buuren HR, Gluud C, Kamath PS, Riggio O, Salerno F, Yacavone RF. Methodology of future trials: prognostic stratification, health related quality of life, and health economics. In: de Franchis R, ed. Portal Hypertension III: Proceedings of the third Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science Ltd. 2001: 219-37.

Gluud C, Kjaergard LL. Quality of randomized clinical trials in portal hypertension and other fields of hepatology. In: de Franchies R, ed. Portal Hypertension III: Proceedings of the Third Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science Ltd. 2001: 204-18.

Gluud C. Alcoholic hepatitis: no glucocorticosteroids? In: Leuschner U, James O, Dancygier H, eds. Steatohepatitis (NASH and ASH) – Falk Symposium 121. Dordrecht: Kluwer Academic Publishers. 2001: (36); 322-42.

Gluud C. The Cochrane Hepato-Biliary Group. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rhodés J, eds. Clinical Hepatology. 2nd ed.. Oxford: University Press. 1999: (Vol. II-Sections 14-32 and Index):2145-48.

Gluud C, Becker U, Borroughs AK, Calès P, Liberati A, Morabito A, Tiné F. Trials in portal hypertension: consensus statements. In: de Franchis R, ed. Portal hypertension II: Proceeding of the second Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science Ltd.. 1996: 210.

Becker U, Burroughs AK, Calés P, Gluud C, Liberati A, Morabito A, Tiné F. Trials in portal hypertension: Valid meta-analysis and valid randomized clinical trial. In: de Franchis R, ed. Portal hypertension II: Proceeding of the second Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science Ltd.. 1996: 180-209.

Members of the CAN-MED ad hoc Working Group on Clinical Research and Clinical Trials, (Buschbeck K, Cunha-Vaz, Hallen M, Cosmi EV, Rodriguez-Farré, Scherstén T, Zichgraf T, Cami J, Corvol P, Dunstan D, Gluud C, Goebell H, Hemmer M, Karma P, Van Der Schuern E, Murphy M, Stordahl A, van Es LA). Report on Scientific Field Review in Clinical Research and Clinical Trials. Biomedical and Health research Programmes [Report]. European Comission, Directorate General XII. 1995: 1-9.

Gluud C, Kok F, Maynard A. Proposal for a strategy for public health research in the European Union regarding consumption patterns, including nutrition, use of licit and illicit drugs, alcohol and tobacco consumption, etc. [Report]. In: Lazar P, Thiers G, ed. Elements for a strategy for public health research in the European Union. European Comission, Directorate General XII. 1995: Ann. 4.22-4.23.